Clinical trials: Non-immunologic
Sébastien Perreault
CHU Sainte Justine
Montréal, Quebec, Canada
François Doz
SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie
Paris, Ile-de-France, France
Birgit Geoerger
Gustave Roussy Cancer Center, Department of Paediatric and Adolescent Oncology, INSERM 1015, Université Paris-Saclay
Villejuif, France
Antoine Italiano
Early Phase Trials Unit, Institut Bergonie
Bordeaux, France
Ulrik N. Lassen
Department of Oncology, Rigshospitalet, University Hospital Copenhagen
Copenhagen, Denmark
Anna Nilsson
Department of Paediatric Oncology, Karolinska University Hospital
Stockholm, Sweden
Karsten Nysom
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet
Copenhagen, Denmark
Jean-Philippine Spano
Pitié-Salpétrière Hospital
Paris, France
Ricarda Norenberg
Chrestos Concept GmbH & Co. KG
Essen, Germany
Vadim Bernard-Gauthier
Bayer HealthCare Pharmaceuticals, Inc.
Toronto, Ontario, Canada
Esther de la Cuesta
Bayer HealthCare Pharmaceuticals, Inc.
Whippany, New Jersey, United States
Alexander Drilon
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Theodore Laetsch
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Cornelis M. van Tilburg
Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
Heidelberg, Germany